BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23202984)

  • 1. Structural analysis of the inhibition of APRIL by TACI and BCMA through molecular dynamics simulations.
    González-Mendióroz M; Alvarez-Vázquez AB; Rubio-Martinez J
    J Mol Graph Model; 2013 Feb; 39():13-22. PubMed ID: 23202984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TACI-dependent APRIL signaling maintains autoreactive B cells in a mouse model of systemic lupus erythematosus.
    Tran NL; Schneider P; Santiago-Raber ML
    Eur J Immunol; 2017 Apr; 47(4):713-723. PubMed ID: 28267197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APRIL and BAFF proteins increase proliferation of human adipose-derived stem cells through activation of Erk1/2 MAP kinase.
    Zonca M; Mancheño-Corvo P; DelaRosa O; Mañes S; Büscher D; Lombardo E; Planelles L
    Tissue Eng Part A; 2012 Apr; 18(7-8):852-9. PubMed ID: 22059379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APRIL promotes breast tumor growth and metastasis and is associated with aggressive basal breast cancer.
    García-Castro A; Zonca M; Florindo-Pinheiro D; Carvalho-Pinto CE; Cordero A; Gutiérrez del Fernando B; García-Grande A; Mañes S; Hahne M; González-Suárez E; Planelles L
    Carcinogenesis; 2015 May; 36(5):574-84. PubMed ID: 25750171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APRIL promotes proliferation, secretion and invasion of fibroblast-like synoviocyte from rats with adjuvant induced arthritis.
    Chang Y; Jia X; Sun X; Xu S; Wu Y; Zhang L; Wei W
    Mol Immunol; 2015 Mar; 64(1):90-8. PubMed ID: 25466610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell maturation antigen (BCMA) activation exerts specific proinflammatory effects in normal human keratinocytes and is preferentially expressed in inflammatory skin pathologies.
    Alexaki VI; Pelekanou V; Notas G; Venihaki M; Kampa M; Dessirier V; Sabour-Alaoui S; Stathopoulos EN; Tsapis A; Castanas E
    Endocrinology; 2012 Feb; 153(2):739-49. PubMed ID: 22166983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.
    Moreaux J; Sprynski AC; Dillon SR; Mahtouk K; Jourdan M; Ythier A; Moine P; Robert N; Jourdan E; Rossi JF; Klein B
    Eur J Haematol; 2009 Aug; 83(2):119-29. PubMed ID: 19456850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple novel classes of APRIL-specific receptor-blocking peptides isolated by phage display.
    Gordon NC; Lien S; Johnson J; Wallweber HJ; Tran T; Currell B; Mathieu M; Quan C; Starovasnik MA; Hymowitz SG; Kelley RF
    J Mol Biol; 2010 Feb; 396(1):166-77. PubMed ID: 19945466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
    Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
    Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAFF, APRIL and their receptors: structure, function and signaling.
    Bossen C; Schneider P
    Semin Immunol; 2006 Oct; 18(5):263-75. PubMed ID: 16914324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma.
    Lee L; Draper B; Chaplin N; Philip B; Chin M; Galas-Filipowicz D; Onuoha S; Thomas S; Baldan V; Bughda R; Maciocia P; Kokalaki E; Neves MP; Patel D; Rodriguez-Justo M; Francis J; Yong K; Pule M
    Blood; 2018 Feb; 131(7):746-758. PubMed ID: 29284597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling Properties.
    Schuepbach-Mallepell S; Das D; Willen L; Vigolo M; Tardivel A; Lebon L; Kowalczyk-Quintas C; Nys J; Smulski C; Zheng TS; Maskos K; Lammens A; Jiang X; Hess H; Tan SL; Schneider P
    J Biol Chem; 2015 Jun; 290(26):16330-42. PubMed ID: 25953898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking.
    Kimberley FC; van Bostelen L; Cameron K; Hardenberg G; Marquart JA; Hahne M; Medema JP
    FASEB J; 2009 May; 23(5):1584-95. PubMed ID: 19141538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD256 can be found in antibody-mediated renal allograft rejection tissues.
    Xu H; He X; Zhao W; Guo H; Shi Q; Zhu Y; Zhang X
    Clin Lab; 2012; 58(5-6):411-8. PubMed ID: 22783569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Silico Identification of Novel APRIL Peptide Antagonists and Binding Insights by Molecular Modeling and Immunosorbent Assays.
    Silva JH; Calmon-Hamaty F; Savino W; Hahne M; Caffarena ER
    Protein Pept Lett; 2015; 22(5):432-42. PubMed ID: 25731591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
    Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
    J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
    Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
    Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced Molecular Dynamics Approaches to Model a Tertiary Complex APRIL/TACI with Long Glycosaminoglycans.
    Marcisz M; Maszota-Zieleniak M; Huard B; Samsonov SA
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation.
    Kim J; Gross JA; Dillon SR; Min JK; Elkon KB
    Autoimmunity; 2011 Mar; 44(2):69-81. PubMed ID: 21250838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of proteoglycans as the APRIL-specific binding partners.
    Ingold K; Zumsteg A; Tardivel A; Huard B; Steiner QG; Cachero TG; Qiang F; Gorelik L; Kalled SL; Acha-Orbea H; Rennert PD; Tschopp J; Schneider P
    J Exp Med; 2005 May; 201(9):1375-83. PubMed ID: 15851487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.